Cutler Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,500
Closed -$2K 3733
2023
Q1
$2K Buy
+1,500
New +$7.74K ﹤0.01% 3130
2022
Q1
Sell
-14,600
Closed -$73K 5510
2021
Q4
$73K Buy
14,600
+13,800
+1,725% +$110K ﹤0.01% 2099
2021
Q3
$9K Hold
800
﹤0.01% 3997
2021
Q2
$16K Hold
800
﹤0.01% 3487
2021
Q1
$22K Sell
800
-100
-11% -$2.95K ﹤0.01% 3130
2020
Q4
$23K Hold
900
﹤0.01% 2569
2020
Q3
$33K Buy
900
+100
+13% +$3.96K ﹤0.01% 2084
2020
Q2
$41K Buy
800
+200
+33% +$8.37K ﹤0.01% 1874
2020
Q1
$18K Sell
600
-3,300
-85% -$174K ﹤0.01% 2366
2019
Q4
$232K Buy
3,900
+1,900
+95% +$85.4K 0.01% 755
2019
Q3
$73K Buy
2,000
+600
+43% +$23.8K 0.01% 1265
2019
Q2
$65K Sell
1,400
-1,000
-42% -$47K 0.01% 1356
2019
Q1
$96K Sell
2,400
-1,100
-31% -$49.3K 0.01% 1021
2018
Q4
$161K Buy
3,500
+600
+21% +$28.9K 0.02% 757
2018
Q3
$128K Buy
+2,900
New +$133K 0.01% 1061
2018
Q2
Sell
-3,700
Closed -$187K 4362
2018
Q1
$267K Buy
3,700
+3,600
+3,600% +$264K 0.02% 667
2017
Q4
$6K Sell
100
-1,666
-94% -$89.7K ﹤0.01% 3475
2017
Q3
$88K Sell
1,766
-9,983
-85% -$481K ﹤0.01% 1768
2017
Q2
$543K Buy
11,749
+4,504
+62% +$166K 0.02% 649
2017
Q1
$255K Sell
7,245
-15,121
-68% -$346K 0.01% 1024
2016
Q4
$280K Buy
22,366
+12,511
+127% +$149K 0.01% 1065
2016
Q3
$136K Sell
9,855
-200
-2% -$2.27K 0.01% 1550
2016
Q2
$99K Buy
10,055
+2,809
+39% +$46.5K 0.01% 1704
2016
Q1
$122K Buy
7,246
+3,668
+103% +$59K 0.01% 1427
2015
Q4
$79K Buy
+3,578
New +$90.3K ﹤0.01% 1988

Other funds holding ESPR